Connor Frey, MD

Connor Frey, MD, internal medicine resident (PGY-1) in the Faculty of Medicine at the University of British Columbia, Vancouver Program.

Articles by Connor Frey, MD

Q+A: Connor Frey, MD, on GLP-1 RAs and menstrual adverse event signals

ByConnor Frey, MD,Joshua Fitch, Senior Editor

July 21st 2026

Connor Frey, MD, explains why semaglutide and tirzepatide, but not liraglutide, generated menstrual adverse event signals in a FAERS pharmacovigilance analysis.

Connor Frey, MD

Articles by Connor Frey, MD

Q+A: Connor Frey, MD, on GLP-1 RAs and menstrual adverse event signals

Latest Updated Articles

Trending on Contemporary OB/GYN

GLP-1 RAs linked to broad menstrual adverse event signals in reproductive-aged patients

A discussion of STI rates, barriers, and home screenings with Damian Alagia III, MD

CMS proposed G-codes for obstetric billing draw concern from ACOG amid coding transition

Q+A: Connor Frey, MD, on GLP-1 RAs and menstrual adverse event signals

CMS' obstetric G-codes cause confusion, perimenopause uncertainty, Zuranolone real-world data